I’m as disappointed as most with the share price, but you can’t build a billion company when 76% is owned by retail, look we got to get realistic, top twenty should hold at least 60%, that way, it’s under lock and key.
Trial results are only a quick fix in the share price, before a sell down begins, partner up Orth-ATI, Celgro Nerve and we will see institutional investment buy ins and big increases in share price
You can’t beat the rinse repeat cycle getting played, sure a good time to buy in a hope for a few cents profit after the next announcement
Reminder - J&J ATI Rotator Cuff clinical trial update coming soon, page-122
-
- There are more pages in this discussion • 97 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OCC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
66.5¢ |
Change
0.115(20.9%) |
Mkt cap ! $139.3M | |||
| Open | High | Low | Value | Volume |
| 56.5¢ | 68.0¢ | 56.5¢ | $2.002M | 3.169M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 9999 | 66.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 67.0¢ | 10000 | 1 |
View Market Depth
| Last trade - 16.10pm 10/10/2024 (20 minute delay) ? |
| OCC (ASX) Chart |